FDA Drug Application (207304) for INCASSIA by AUROBINDO PHARMA LTD

Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Application Number207304
Product Number001
FormTABLET;ORAL-28
Dosage0.35MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB1 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameINCASSIA
Active IngredientNORETHINDRONE

Active IngredientCount
List of drugs with Active Ingredient NORETHINDRONE82


Back to FDA Applications sponsored by AUROBINDO PHARMA LTD